GovChime
Notice ID: 01972a08453041a8a53ab1c0c5a961ceCombined Synopsis/Solicitation

Amendment #002-Mammalian Bioreactor Control System � Brand Name or Equal

Archived on October 12, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−04:00
Posted
September 26, 2023
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIAID
Last updated
Dec 4, 2025

Identifiers

Solicitation number
RFQ-NIAID-23-2177803
Notice ID
01972a08453041a8a53ab1c0c5a961ce

Description

Amendment #002, dated September 26, 2023. See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions remain the same. The due date has been changed to 9:00 am EDT on Wednesday, September 27, 2023. This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ). The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC). The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:RFQ-NIAID-23-2177803
  1. Combined Synopsis
  1. 3×
    Combined SynopsisCurrentSep 20, 2023

    Amendment #002-Mammalian Bioreactor Control System � Brand Name or Equal

    Notice 01972a08453041a8a53ab1c0c5a961ce on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

RFQ-NIAID-23-2177803

Archive Date

Oct 12, 2023

Office Address

BETHESDA, MD, 20892